Avery Halmekangas

• Identified, documented, and escalated clinically significant behavioral, psychiatric, and safety concerns to treating psychiatrists to support patient risk assessment and treatment planning.
• Administer 10–15 weekly TMS treatments and monitor 20–35 weekly Spravato® (esketamine) treatment sessions for patients with severe treatment-resistant depression.
• Observe, document, and communicate clinically significant changes in patient presentation, treatment response, and safety status to psychiatric providers to support risk assessment and continuity of care.
• Identify and escalate adverse events, psychiatric concerns, and safety risks within an outpatient psychiatric treatment setting.
• Collaborate with psychiatrists to support treatment planning, patient safety, and continuity of care.
• Maintain accurate clinical documentation using AdvancedMD and Athena Health EHR systems.

Naturalistic Observation of Social Interaction (NOSI) Lab

Supervisor: Matthias Mehl, Ph.D

• Conducted behavioral coding and observational analysis of 5,000+ naturalistic audio recordings using standardized coding protocols and a structured coding manual.
• Analyzed longitudinal observational data examining environmental and social factors associated with suicide risk among adolescents following a recent suicide attempt and psychiatric hospitalization.
• Identified and coded participant affect, social interactions, behavioral patterns, and environmental context from de-identified archival recordings.
• Managed research data and quality assurance procedures using REDCap.
• Contributed to a multi-site research collaboration with Brown University while maintaining strict participant confidentiality.